Batches of an adrenaline pen used to treat acute allergic reactions are being recalled as there have been reports of failure to activate outside of Ireland.
The Health Products Regulatory Authority said that all batches of Emerade pre-filled pens have been recalled.
It said the recall is taking place as some Emerade pens may fail to produce an injection when used, due to failure of the pen to activate and the potential for a blocked needle.
The affected products are all batches of:·
- Emerade 150mcg pre-filled pens·
- Emerade 300mcg pre-filled pens·
- Emerade 500mcg pre-filled pens
The HPRA said that if a patient is in possession of any Emerade pen, they should return it to their pharmacy, where they will receive a replacement alternative product.
No other brand of adrenaline pens is impacted by this recall by PharmaSwiss.
Health authorities have said the Emerade pen is one of the least used, with about 6-8% of the market.
